Qiagen (QGEN) Gross Margin (2009 - 2025)

Qiagen (QGEN) posted Gross Margin of 60.19% for Q4 2025, down 3.23% sequentially from 62.2% in Q3 2025, and up 2529.0% YoY from 2.29% in Q4 2024.

Qiagen (QGEN) Gross Margin (2009 - 2025) Analysis & Trends

Qiagen has reported Gross Margin for 17 years, with the latest figure at 60.19% in Q4 2025.

Quarterly Gross Margin rose 2529.0% year-over-year to 60.19% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 62.18% (up 2207.0% YoY) and the FY2025 annual result came in at 62.18%, up 1328.0% from the prior year.
Gross Margin retreated to 60.19% in Q4 2025 per QGEN's latest filing, from 62.2% in the prior quarter.
Over five years, Gross Margin peaked at 66.04% in Q1 2022 and troughed at 7.0% in Q2 2024.
A 5-year average of 57.28% and a median of 63.08% in 2023 frame the typical range for Gross Margin.
The sharpest annual moves came in 2024 and 2025: Gross Margin slumped 5608 bps in 2024, then surged 5565 bps in 2025.
Over 5 years, Gross Margin stood at 32.94% in 2021, then jumped by 94 bps to 63.76% in 2022, then dropped by 3 bps to 62.08% in 2023, then plunged by 44 bps to 34.9% in 2024, then soared by 72 bps to 60.19% in 2025.
According to Business Quant data, Gross Margin over the past three periods registered 60.19%, 62.2%, and 62.65% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	69.57%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	57.64%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	64.04%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	53.95%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	32.85%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	99.91%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	66.44%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	63.29%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	33.75%
10	Qiagen	8.65 Bn	8.65 Bn	-	-

Download Data